Income statement
USD
Annual
| Metric | 2021 | 2014 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|
| Revenue | 140K | 11M | 27M | 41M | 32M |
| Gross Profit | 140K | 0 | 0 | 0 | 0 |
| Operating Income | 49K | 9M | -19M | -2M | -3M |
| EBITDA | 49K | 9M | -19M | -2M | -3M |
| Net Income | 49K | 9M | -12M | -637K | 4M |
| EPS (Diluted) | — | — | — | — | — |
Financial Services
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 9, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Terme Bancorp, Inc. (TMEB) is a Financial Services stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 9, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow +376.2% with operating margin 35.3% and ROIC 24.0%. Valuation is more restrained than many high-expectation growth names at P/E 0.8 and price/sales 0.3. Stock Foundry combines TMEB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TMEB
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TMEB Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TMEB and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$31.7M
-23.4% YoY
FY Net Income
$4.3M
+779.9% YoY
Free Cash Flow
-$26.4M
+40.8% YoY
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
100.0%
Net Margin
35.3%
Income statement
USD
| Metric | 2021 | 2014 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|
| Revenue | 140K | 11M | 27M | 41M | 32M |
| Gross Profit | 140K | 0 | 0 | 0 | 0 |
| Operating Income | 49K | 9M | -19M | -2M | -3M |
| EBITDA | 49K | 9M | -19M | -2M | -3M |
| Net Income | 49K | 9M | -12M | -637K | 4M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2021 | 2020 | 2014 | 2013 | 2002 |
|---|---|---|---|---|---|
| Cash & Equivalents | 7K | 7K | 42K | 47 | 0 |
| Total Assets | 206K | 157K | 142K | 47 | 344M |
| Total Liabilities | 102K | 102K | 63K | 185K | 336M |
| Shareholder Equity | 105K | 55K | 80K | -185K | 8M |
| Total Debt | 100K | 100K | 61K | -32K | 39M |
| Net Debt | 93K | 93K | 18K | -32K | 39M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
23M
+29.8% YoY
Capital Expenditures
4M
+70.4% YoY
Free Cash Flow
26M
+40.8% YoY
Key ratios
Gross Margin
100.0%
Operating Margin
35.3%
Net Margin
35.3%
ROE
61.9%
Debt / Equity
0.96x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.